A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy

BACKGROUND: This randomized, double-blind, placebo-controlled study evaluated dose-response relationships of lisdexamfetamine dimesylate when used as augmentation for major depressive disorder in individuals exhibiting inadequate responses to antidepressant monotherapy. METHODS: Eligible adults (18–...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Cynthia, Iosifescu, Dan V, Mago, Rajnish, Sarkis, Elias, Reynolds, James, Geibel, Brooke, Dauphin, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606302/
https://www.ncbi.nlm.nih.gov/pubmed/28857719
http://dx.doi.org/10.1177/0269881117722998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606302/
https://www.ncbi.nlm.nih.gov/pubmed/28857719
http://dx.doi.org/10.1177/0269881117722998

Ejemplares similares